Authors: Mata, JE Jackson, JD Joshi, SS Tracewell, WG Pirruccello, SJ Murphy, BJ Bishop, MR Iversen, PL

Citation: Je. Mata et al., Pharmacokinetics and in vivo effects of a six-base phosphorothioate oligodeoxynucleotide with anticancer and hematopoietic activities in swine, J HEMATH ST, 9(2), 2000, pp. 205-214

Authors: Mata, JE Bishop, MR Tarantolo, SR Angle, CR Swanson, SA Iversen, PL

Citation: Je. Mata et al., Evidence of enhanced iron excretion during systemic phosphorothioate oligodeoxynucleotide treatment, J TOX-CLIN, 38(4), 2000, pp. 383-387

Authors: Iversen, PL Cornish, KG Iversen, LJ Mata, JE Bylund, DB

Citation: Pl. Iversen et al., Bolus intravenous injection of phosphorothioate oligonucleotides causes hypotension by acting as alpha(1)-adrenergic receptor antagonists, TOX APPL PH, 160(3), 1999, pp. 289-296

Authors: Page, TJ Mata, JE Bridge, JA Siebler, JC Neff, JR Iversen, PL

Citation: Tj. Page et al., The cytotoxic effects of single-stranded telomere mimics on OMA-BL1 cells, EXP CELL RE, 252(1), 1999, pp. 41-49